regulates antibody responses and subsequent B-cell effector functions to exogenous antigens. However, the role of miR-155 in systemic autoimmunity is not known. Using the death receptor deficient (Fas lpr ) lupus-prone mouse, we show here that ablation of miR-155 reduced autoantibody responses accompanied by a decrease in serum IgG but not IgM anti-dsDNA antibodies and a reduction of kidney inflammation. MiR-155 deletion in Fas lpr B cells restored the reduced SH2 domain-containing inositol 5′-phosphatase 1 to normal levels. In addition, coaggregation of the Fc γ receptor IIB with the B-cell receptor in miR-155 Mice harboring ubiquitous or B-cell-specific ablation of the death receptor Fas develop a severe lupus-like disease. B-cellspecific deletion of the death receptor (fas −/− ) fas −/− mice develop an excessive germinal center (GC)-derived IgG autoantibody deposition in their kidneys and succumb to renal failure (5). It has been suggested that loss of tolerance in lpr mice results from the down-regulation of the low-affinity IgG inhibitory receptor FcγRIIB (Fc γ receptor IIB), thereby rendering their B cells incapable of terminating stimulatory signals delivered by autoantigen-containing immune complexes (6-8). However, the mechanisms whereby lack of FcγRIIB engagement would lead to autoimmunity, and whether additional factors contribute to autoimmunity, are still unclear.
MicroRNA-155 (miR-155) regulates antibody responses and subsequent B-cell effector functions to exogenous antigens. However, the role of miR-155 in systemic autoimmunity is not known. Using the death receptor deficient (Fas lpr ) lupus-prone mouse, we show here that ablation of miR-155 reduced autoantibody responses accompanied by a decrease in serum IgG but not IgM anti-dsDNA antibodies and a reduction of kidney inflammation. MiR-155 deletion in Fas lpr B cells restored the reduced SH2 domain-containing inositol 5′-phosphatase 1 to normal levels. In addition, coaggregation of the Fc γ receptor IIB with the B-cell receptor in miR-155 −/− -Fas lpr B cells resulted in decreased ERK activation, proliferation, and production of switched antibodies compared with miR-155 sufficient Fas lpr B cells. Thus, by controlling the levels of SH2 domaincontaining inositol 5′-phosphatase 1, miR-155 in part maintains an activation threshold that allows B cells to respond to antigens.
ERK pathways | SHIP-1 M icroRNA-155 (miR-155) plays a critical role in the generation of effective antibody responses to exogenous antigenic challenges in mice (1) (2) (3) . MiR-155 levels have been reported to be elevated in B but low in T cells from patients with systemic lupus erythamosus (4), yet it is not known whether miR-155 controls autoimmune responses and the expression of related pathology.
Mice harboring ubiquitous or B-cell-specific ablation of the death receptor Fas develop a severe lupus-like disease. B-cellspecific deletion of the death receptor (fas −/− ) fas −/− mice develop an excessive germinal center (GC)-derived IgG autoantibody deposition in their kidneys and succumb to renal failure (5) . It has been suggested that loss of tolerance in lpr mice results from the down-regulation of the low-affinity IgG inhibitory receptor FcγRIIB (Fc γ receptor IIB), thereby rendering their B cells incapable of terminating stimulatory signals delivered by autoantigen-containing immune complexes (6) (7) (8) . However, the mechanisms whereby lack of FcγRIIB engagement would lead to autoimmunity, and whether additional factors contribute to autoimmunity, are still unclear.
The SH2 domain-containing inositol 5′-phosphatase 1 (SHIP-1) phosphatase acts downstream of inhibitory cell-surface receptors (9) (10) (11) (12) , including the FcγRIIB, which is essential in opposing B-cell activation signals in mice and humans (13, 14) . FcγRIIB inactivation has been implicated in the development of autoreactive GC B cells and plasma cells (15) , as well as in the regulation of the persistence and longevity of bone marrow plasma cells (16) . After coligation of the FcγRIIB with the B-cell receptor (BCR), FcγRIIB recruits SHIP-1 to the plasma membrane, where it negatively regulates cell survival, Ca 2+ -dependent effector functions, and ERK activation, thus controlling cell proliferation, anergy, and apoptosis (17) (18) (19) (20) (21) (22) (23) . As a consequence of these wideranging activities, germ-line or B-cell-specific deletion of FcγRIIB or SHIP-1 in mice results in a severe lupus-like disease characterized by high-titer serum IgG antinuclear autoantibodies, lymphadenopathy, splenomegaly, renal failure, and increased mortality (23) (24) (25) (26) (27) . MiR-155 has been reported to regulate SHIP-1 expression in mammalian myeloid and malignant B cells (28) (29) (30) (31) . However, it is not known whether SHIP-1 regulation by miR-155 affects GC reactions or peripheral tolerance during a protective immune response or in an autoimmune environment, such as that in 
Significance
The host immune system provides diverse defense mechanisms to fight harmful bacteria and viruses. One of these mechanisms is the production of antibodies targeting infectious agents. However, the production of antibodies has to be tightly controlled. Insufficient control of the immune system may result in the development of autoimmune diseases, including lupus. Lupus is characterized by the production of antibodies attacking the kidneys, leading to life-threatening kidney failure if untreated.
In this study, we show that microRNA-155, one member of a family of regulatory molecules, promotes the production of antibodies. By deleting microRNA-155, we can prevent the production of harmful antibodies and alleviate lupus-like disease in mice. Our results suggest the possibility of targeting microRNA-155 to treat autoimmune diseases. (33, 34) . We and others have previously shown that GC reactions and subsequent B-cell effector functions are regulated by miR-155 (1-3). We thus asked whether miR-155 deletion would mitigate spontaneous GC reactions in fas-deficient mice. Flow cytometry confirmed that compared with the age-matched B6 parental strain, 10-to 12-mo-old Fas lpr mice had a higher frequency of B cells with the GC phenotype, peanut agglutinin (PNA) + GL7 + ( Fig.  2A) . However, the frequency of GC-phenotype B cells in miR-155 −/− -Fas lpr spleens (1.75% ± 0.65%) and pLNs (0.76% ± 0.29%) was fivefold and 12-fold lower, respectively, compared with Fas lpr mice (spleen GC B cells 8.82% ± 0.4%, P < 0.0001; pLN GC B cells 9.0% ± 0.9%, P = 0.0013, Fig. 2 A-C) . The lower GC B-cell frequency corresponded to a statistically significant reduction in the total number of spleen GC B cells in miR-155 −/− -Fas lpr mice (Fig. 2D) . Thus, in miR-155 −/− -Fas lpr mice, both the frequency and total number of spleen and the frequency of pLN GC B cells were normalized to the levels seen in B6 and miR-155 −/− control mice. At the time of analysis, aged (10-12 mo old) Fas lpr mice developed severe lymphadenopathy with many large pLNs, possibly generated from the fusion of many nodes, making it difficult to confidently ascertain that the absolute number of GC B cells observed were representative of individual pLNs. Histologically, PNA staining of follicular structures confirmed spontaneous GC formation in Fas lpr lymphoid tissues ( those in B6 and miR-155 −/− control mice (Fig. 2E , arrows indicate GCs). Therefore, in addition to controlling GC formation in response to exogenous antigens (1), miR-155 participates in autoantigen-driven GC reactions in the Fas lpr mouse.
Serum IgG Anti-dsDNA Autoantibodies Are Decreased in miR-155
A marker of human systemic lupus erythamosus is the presence of high-titer IgG autoantibodies against nuclear autoantigens, especially dsDNA (35, 36) . Similarly, aged Fas lpr or B-cell-specific fas-deficient mice produce excessive amounts of autoantibodies directed against dsDNA or ssDNA autoantigens (5, 32). As early as 8 wk of age and before the onset of overt kidney pathology, total serum IgM and IgG anti-dsDNA autoantibodies were high in Fas lpr mice compared with B6 controls, as expected ( Fig. 3 A and B) . By contrast, miR-155 −/ − -Fas lpr mice had ∼twofold lower levels of total IgG antidsDNA autoantibodies at all ages examined (Fig. 3B, * Fig. 3 C-E) . By contrast, we observed a higher frequency of class-switched cells in the Fas lpr cultures (29%), which corresponded to a higher frequency of divided cells (69%, Fig. 3 C-E S3 A  and B) . Our data suggest that in the lpr autoimmune environment, miR-155 controls the homeostasis of switched autoreactive B cells. compared with the large amounts of IgG seen in Fas lpr kidneys (Fig. 4A) . The IgG signal intensity in B6 and miR-155 −/− control kidneys was negligible (Fig. 4A) . By contrast, IgM deposition remained similar in kidneys of Fas lpr and miR-155
-Fas lpr mice, consistent with the fact they had comparable levels of serum IgM (Fig. 4A) . Extensive IgG positivity was also observed in the medulla and vessels of Fas lpr kidneys but not in the corresponding areas of miR-155 −/− -Fas lpr kidneys (Fig. S4 A and B) . Histopathologic analyses of kidneys from Fas lpr mice showed enhanced mononuclear cell infiltration, disrupted architecture, and enlarged glomeruli (Fig. 4B and Fig. S5 , thick and thin arrows indicate glomeruli and vessels, respectively). By contrast, the kidneys of age-matched miR-155 −/− -Fas lpr , B6, and miR-155 −/− mice showed little or no abnormalities in the overall architecture, negligible levels of mononuclear cell infiltration, and contained normal-size glomeruli, correlating with the absence of IgG staining. Lower serum IgG autoantibody levels were associated with improved renal clinical parameters in miR-155 −/− -Fas lpr mice (Table S1 ). Urinalysis of the compound mutant mice, using Multistix strips, revealed only trace amounts of blood and an undetectable number of lymphocytes, similar to WT B6 and miR-155 −/− mice. Although the level of urinary proteins in the miR-155 −/− -Fas lpr mice was higher than that of WT B6 and miR-155 −/− mice, it was fourfold lower than in Fas lpr mice (53 ± 36 vs. 260 ± 89, P = 0.0006). Collectively, our results demonstrate that targeting miR-155 in the lupus-prone Fas lpr mouse leads to decreased IgG deposition and renal damages.
MiR-155 Modulates SHIP-1 Expression and the Downstream ERK
Kinase Pathway After BCR and FcγRIIB Coligation. Although our data suggest that miR-155 plays an essential role in regulating autoantibody responses in lupus-prone Fas lpr mice, the mechanisms by which miR-155 exerts its regulatory functions are not readily apparent. It has been proposed that miR-155 regulates SHIP-1 expression in mammalian myeloid and malignant B cells (28) (29) (30) (31) . However, it is not known whether SHIP-1 regulation by miR-155 affects GC reactions or peripheral tolerance during a protective immune response or in an autoimmune environment, such as that in Fas lpr mice. We previously showed that although miR-155 levels are negligible in resting B cells, stimulation induces a transient peak of miR-155 expression at 24 h (1). Because spleens from Fas lpr mice contained B cells with an activated/GC phenotype, we asked whether miR-155 would be detected in these cells. As shown in Fig. 5A, resting (Fig. 5C ). Fas lpr B cells displayed a higher level of ERK activation after engagement of the BCR and the FcγRIIB, corresponding to the lower level of SHIP-1 seen in these cells. In the absence of FcγRIIB coengagement [goat IgG (Fab') 2 ], hence no inhibitory signal, the ERK activation state remained similar in spleen B cells from mice of all genotypes (Fig. 5D ). There was negligible ERK activation in all unstimulated cultures. Thus, our results implicate miR-155 in the suppression of SHIP-1 while promoting the activation of the ERK-kinase signaling pathway in both nonautoimmune and autoimmune mice. The elevated ERK activation status observed in Fas lpr B cells likely results from reduced SHIP-1 expression levels in these cells. Our observations suggest a mechanism whereby miR-155 controls SHIP-1 levels to maintain a certain B-cell activation threshold after coaggregation of the BCR and FcγRIIB by immune complexes.
MiR-155 Controls B-Cell Proliferation Through SHIP-1. Because SHIP-1 controls cell proliferation after BCR and FcγRIIB coligation, we reasoned that the increased SHIP-1 expression and decreased ERK activation would lead to a lower proliferation rate of miR-155 −/− and miR-155
-Fas lpr activated B cells, and that engagement of the BCR alone would have no effects. After BCR and FcγRIIB coengagement, cell proliferation was decreased in all cultures compared with activation through the BCR alone (Fig. 6 A and B) . However, after coligation of the BCR and FcγRIIB, we observed a further 1.9-fold reduction in the frequency of divided cells in miR-155 −/− B-cell cultures (14% ± 1%) compared with B6 (26% ± 1.2%, *P = 0.0003, Fig. 6B ). (Fig. S6) . The proliferation rate between B6 (26% ± 1.2%) and miR-155
lpr (23% ± 3%) cultures remained similar. There was no appreciable difference in the frequency of divided cells or cell death in all cultures in the absence of FcγRIIB coaggregation (Fig. 6 A and B and Fig. S6 ). After coligation of the BCR and FcγRIIB, miR-155 −/− and miR-155
-Fas lpr cultures contained more dead cells compared with controls, as measured by the DNA vital dye TO-PRO-3 (Fig. S7) . As expected, the percentage of cell death was highest in all cultures that did not receive stimuli (Fig. S7) . Thus, miR-155 deficiency normalized Fas lpr B-cell proliferation rate to that of B6. We propose that the reduction of autoreactive B cells in the miR-155 −/− -Fas lpr mouse results in part from the recovery of SHIP-1 expression, leading to an attenuation of B-cell activation pathways induced by immune complexes.
Discussion
In this study, we asked whether and how miR-155 regulates systemic autoimmunity. We find that ablation of miR-155 reduces autoantigen-induced GC reactions in spleens and pLNs of lupus-prone fas-deficient mice. There was a strong decrease in the level of serum In human and mouse, switched autoantibodies to nuclear antigens are shown to be derived from both extrafollicular and GC reactions (15, (37) (38) (39) (40) (41) (42) (43) (44) (45) . In response to exogenous antigens, miR-155 regulates both GC and non-GC reactions. Therefore, our results suggest that in the Fas lpr mouse, targeting miR-155 likely affects both GC and extrafollicular responses, leading to the reduction of IgG autoantibodies, which are pathogenic.
Mice harboring B-cell-specific FcγRIIB or SHIP-1 deletion develop severe lupus-like disease characterized by the presence of high-titer serum antinuclear and antikidney autoantibodies, lymphadenopathy, splenomegaly, and renal pathologies (23) (24) (25) (26) (27) . Thus, our results suggest that miR-155 in part modulates the expression level of SHIP-1 after coligation of the BCR and FcγRIIB by immune complexes. SHIP-1 in turn regulates the threshold of B-cell activation through the ERK signaling pathway. By targeting miR-155 in the Fas lpr mouse, we could block the persistent activation of switched autoreactive B cells, thus alleviating lupus-like disease. Our results offer insights into how autoimmunity is regulated by miR-155 and suggest the possibility of targeting miR-155 to treat autoimmunity while preserving the protective immunity (46, 47) . Urinalysis. To determine kidney functions, urine was collected from aged mice. Multistix 10 SG strips and the CLINITEKStatus machine (Siemens) were used to determine the presence of blood, lymphocytes, and proteins in urine samples. In Vitro B-Cell Activation and Isotype Switch Assay. Magnetic-activated cell sorting (MACS)-purified (Miltenyi Biotec) CD43 − or CD19 + B cells were activated in vitro at a density of 1-3 × 10 6 cells/mL with 2 μg/mL of anti-CD40 clone HM40-3 (eBiosciences) plus 25 ng/mL of recombinant mouse IL-4 (R&D Systems), 10 μg/mL of goat F(ab') 2 anti-mouse IgM, or with 10 μg/mL of goat IgG (intact) anti-mouse IgM antibody (Jackson Immunoresearch).
Materials and Methods

Proliferation Assays and Analysis. MACS-purified CD43
− B cells labeled with
Carboxyfluorescein succinimidyl ester (CFSE) CFSE were activated with indicated stimuli as above for 3 or 4 d. Data were analyzed using the proliferation platform of FlowJo software (Tree Star).
Western Immunoblot Assays. Pellets were lysed with RIPA buffer containing protease inhibitors (Roche). The following antibodies were used: rabbit anti-SHIP-1 monoclonal antibody (catalog no. 2727), rabbit anti-phospho-p44/42 (pErk1/2) MAPK antibody, and rabbit anti-p44/42 (Erk1/2) MAPK antibody; all antibodies were purchased from Cell Signaling Technology. Anti-mouse β-actin was purchased from Sigma-Aldrich. For chemiluminescence detection, we used the Fujifilm LAS-4000 imaging system.
Northern Blot Assays. Northern blots were carried out using the Signosis high sensitive system per the manufacturer's suggestions (Signosis). Briefly, 2 μg of total RNA was separated through gel electrophoresis and transferred onto a membrane. Expression of miR-155 or U6 was detected with a biotinlabeled probe. For chemiluminescence detection, we used the Fujifilm LAS-4000 imaging system.
Statistical Analysis. P values were determined by applying Student's twotailed t test for independent samples, assuming equal variances on all experimental data sets, using the online t test calculator from GraphPad Software.
